Aciex granted Akorn worldwide rights to an undisclosed OTC eye care product and manufacturing rights for an undisclosed prescription product

Aciex Therapeutics Inc.

U.S. / Private Biopharma

Licensor / Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!; This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Akorn Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Licensee / Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!; This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced